E-Selectin Reduces Atherosclerosis in Mice
Author Information
Author(s): Li Xinhui, Johnson Kory R., Bryant Mark, Elkahloun Abdel G., Amar Marcelo, Remaley Alan T., De Silva Ranil, Hallenbeck John M., Quandt Jacqueline A.
Primary Institution: National Institutes of Health
Hypothesis
Can intranasal delivery of E-selectin reduce atherosclerosis in ApoE−/− mice?
Conclusion
Intranasal delivery of E-selectin significantly reduced atherosclerosis and serum cholesterol levels in ApoE−/− mice.
Supporting Evidence
- Intranasal delivery of E-selectin reduced lipid lesions in the aorta.
- Serum total cholesterol levels were significantly lower in E-selectin treated mice.
- E-selectin tolerization led to a significant reduction in macrophage infiltration in aortic roots.
Takeaway
Giving a special protein called E-selectin through the nose can help mice with heart problems by making their blood vessels healthier.
Methodology
Female ApoE−/− mice received intranasal E-selectin or PBS and were placed on a high-fat diet for 7 weeks to assess atherosclerosis.
Potential Biases
Potential bias in animal model selection and treatment administration.
Limitations
The study was conducted in mice, and results may not directly translate to humans.
Participant Demographics
Female ApoE−/− mice, aged 9 weeks at the start of the study.
Statistical Information
P-Value
0.003
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website